Floxzar 10mg Injection
Marketer
Taj Pharma India Ltd
Salt Composition
Carboplatin (10mg)
Overview Floxzar 10mg Injection
Oncasin 10mg Injection treats ovarian and small-cell lung cancers by inhibiting or reducing cancerous cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can lower blood cell counts (red and white), increasing infection or bleeding risk. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests are vital to monitor blood cell levels, along with heart, liver function, and uric acid. Report any allergic reactions, such as skin rash, itching, or breathing difficulties. Inform your healthcare provider of all medications you take, as interactions are possible. This injection is contraindicated during pregnancy or breastfeeding; effective contraception is crucial for both partners during treatment.
Uses of Floxzar 10mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Floxzar 10mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Floxzar 10mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Floxzar 10mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Floxzar 10mg Injection works:
Oncasin 10mg Injection is a chemotherapeutic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) of malignant cells, thereby inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Floxzar 10mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Floxzar 10mg Injection to pregnant individuals poses a confirmed risk to the fetus. Its use during pregnancy is therefore contraindicated, except in exceptional, life-threatening circumstances where the potential benefits outweigh the known dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Floxzar 10mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingUNSAFE
Administering Floxzar 10mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Administering Floxzar 10mg Injection to individuals with impaired renal function requires careful consideration. Dosage modification of Floxzar 10mg Injection might be necessary. Physician consultation is recommended. Floxzar 10mg Injection is contraindicated in patients exhibiting severe kidney disease. Routine assessment of kidney function is advisable during treatment.
LiverSAFE IF PRESCRIBED
The use of Floxzar 10mg Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Floxzar 10mg Injection :
Omitting a scheduled dose of Floxzar 10mg Injection warrants immediate medical advice.
Facts to Know About Floxzar 10mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Platinum Equivalents |
| Developing Habits | No. |
| Type of Therapy | Cancer Therapeutics |
| Action Category | Platinum-based Anticancer Agents |
3,018 People bought this recently